Finance

Lists
Why is AURA up 4.70%?
Dive Deeper
AURA:NASDAQ
Aura Biosciences Inc
$6.46
+4.70%
(+0.29) 1D
$6.46
0.00% (0.00)
After hours
Closed: Oct 7, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AURA...
Open
$6.10
High
$6.56
Low
$6.10
Mkt. cap
669.93M
Avg. vol.
863.04K
Volume
0.00
52-wk high
$9.54
52-wk low
$4.73
EPS
-$1.76
Beta
0.41
Shares outstanding
103.70M
No. of employees
113
Open
$6.10
High
$6.56
Low
$6.10
Mkt. cap
669.93M
Avg. vol.
863.04K
Volume
0.00
52-wk high
$9.54
52-wk low
$4.73
EPS
-$1.76
Beta
0.41
Shares outstanding
103.70M
No. of employees
113
News stories
From web sources and news partners
The Daily News | Texas' Oldest Newspaper
The Daily News | Texas' Oldest Newspaper
·
51 minutes ago
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City
Magnolia Banner News
Magnolia Banner News
·
13 minutes ago
Wall Street retreats from its record as stocks fall worldwide
The Globe and Mail
The Globe and Mail
·
1 hour ago
U.S. Analyst Updates: October 7th, 2026
Investor's Business Daily
Investor's Business Daily
·
2 hours ago
Futures: Memory Giant's Earnings Surge, But Miss Views
About Aura Biosciences Inc
CEO-
Employees113
Founded2009
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websiteaurabiosciences.com
Analyst ratings
Based on 2 analysts giving stock ratings to AURA in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for AURA in the last 3 months.
Highest
Current $6.46
$23.00 (+256.04%)
Average
$20.50 (+217.34%)
Lowest
$18.00 (+178.64%)
Analyst
Recommendation
Action
Price target
Projected
Date
Oliver McCammon
LifeSci Capital
Buy
Maintained
$23.00
+256%
08/12/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
$18.00
+178.6%
08/12/2026
Andrew Berens
Leerink Partners
Buy
Reiterated
-
-
06/02/2026
Phil Nadeau
TD Cowen
Buy
Maintained
-
-
05/11/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
$15.00
+132.2%
04/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
22.18M
21.90M
27.96M
30.75M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.73M
5.34M
6.91M
17.32M
Operating expense
27.91M
27.24M
34.87M
48.07M
Total operating expenses
27.91M
27.24M
34.87M
48.07M
Operating income
-27.91M
-27.24M
-34.87M
-48.07M
Other non operating income
-13.00K
149.00K
2.00K
154.00K
EBT including unusual items
-26.10M
-25.54M
-33.67M
-45.61M
EBT excluding unusual items
-26.10M
-25.54M
-33.67M
-45.61M
Income tax expense
26.00K
15.00K
11.00K
29.00K
Effective tax rate
-0.10%
-0.06%
-0.03%
-0.06%
Other operating expenses
-
-
-
-
Net income
-26.13M
-25.56M
-33.68M
-45.64M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
1.82M
1.54M
1.19M
2.31M
Interest expense
-
-
-
-
Net interest expenses
1.82M
1.54M
1.19M
2.31M
Depreciation and amortization charges
-
-
-
-
EBITDA
-27.63M
-26.96M
-34.59M
-47.81M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps